Literature DB >> 8507447

Left ventricular mass and geometry in patients with established hypertension and white coat hypertension.

A Høegholm1, K S Kristensen, L E Bang, J W Nielsen, W B Nielsen, N H Madsen.   

Abstract

This study was designed to compare the cardiac mass and geometry in white coat hypertensive patients and established hypertensive patients through the prospective comparison of office blood pressure, daytime ambulatory blood pressure, and echocardiographically determined left ventricular mass and cardiac geometry in consecutive patients. We studied 143 patients from general practice in an outpatient hypertension unit. The patients had newly diagnosed mild-to-moderate hypertension prior to the institution of pharmacological anti-hypertensive therapy. All patients had a diastolic office blood pressure above 90 mm Hg; 90 had a consistently elevated diastolic blood pressure (established hypertension), whereas 53 had an average daytime ambulatory blood pressure below 90 mm Hg (white coat hypertension). Left ventricular mass index was significantly higher in the group with established hypertension, 102.4 +/- 26.6 g/m2 (mean +/- SD) v 93.6 +/- 23.5 (P = .045). Relative wall thickness was likewise significantly higher, 0.36 +/- 0.07 v 0.33 +/- 0.06 (P = .004). There was no significant difference in left atrial dimension. In a multiple regression model the ambulatory measurements and not the office measurements were statistically significantly associated with the extent of cardiac hypertrophy. Further, 44/53 (83%) of the patients with white coat hypertension had normal left ventricular dimensions, versus only 55/90 (61%) of the patients with established hypertension (P = .033). Thus, white coat hypertensive patients display less cardiac involvement than patients with established hypertension, indicating that they should rather be treated as normotensives than as hypertensives, ie, not with pharmacological antihypertensive therapy.

Entities:  

Mesh:

Year:  1993        PMID: 8507447     DOI: 10.1093/ajh/6.4.282

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  7 in total

Review 1.  Closer look at white-coat hypertension.

Authors:  Nurver Turfaner Sipahioglu; Fikret Sipahioglu
Journal:  World J Methodol       Date:  2014-09-26

2.  Raised urinary glucocorticoid and adrenal androgen precursors in the urine of young hypertensive patients: possible evidence for partial glucocorticoid resistance.

Authors:  W Shamim; M Yousufuddin; D P Francis; P Gualdiero; J W Honour; S D Anker; A J Coats
Journal:  Heart       Date:  2001-08       Impact factor: 5.994

Review 3.  Ambulatory blood pressure monitoring.

Authors:  T G Pickering
Journal:  Curr Hypertens Rep       Date:  2000-12       Impact factor: 5.369

4.  Changes in left ventricular structure and function in patients with white coat hypertension: cross sectional survey.

Authors:  M W Muscholl; H W Hense; U Bröckel; A Döring; G A Riegger; H Schunkert
Journal:  BMJ       Date:  1998-08-29

Review 5.  Blood pressure and progression of chronic kidney disease: importance of systolic, diastolic, or diurnal variation.

Authors:  Evelyn Mentari; Mahboob Rahman
Journal:  Curr Hypertens Rep       Date:  2004-10       Impact factor: 5.369

6.  Combination of Echocardiography and Pulse Wave Velocity Provides Clues for the Differentiation between White Coat Hypertension and Hypertension in Postmenopausal Women.

Authors:  Hiromichi Suzuki; Kazuhiro Kobayashi; Hirokazu Okada
Journal:  Pulse (Basel)       Date:  2014-04-09

Review 7.  White-Coat Hypertension: the Neglected Subgroup in Hypertension.

Authors:  Cesare Cuspidi; Marijana Tadic; Giuseppe Mancia; Guido Grassi
Journal:  Korean Circ J       Date:  2018-07       Impact factor: 3.243

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.